Sales/Maturities of Investments

$368.93M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$368.93Mperiod endingJun 30, 2026

BCRX Sales/Maturities of Investments ($5.20M → $368.93M)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

BCRX sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	256,647,000
Dec 31, 2024	320,480,000
Dec 31, 2023	385,077,000
Dec 31, 2022	117,396,000
Dec 31, 2021	28,201,000
Dec 31, 2020	43,475,000
Dec 31, 2019	81,295,000
Dec 31, 2018	67,748,000
Dec 31, 2017	43,461,000
Dec 31, 2016	42,652,000
Dec 31, 2015	42,410,000
Dec 31, 2014	34,000,000
Dec 31, 2013	20,330,000
Dec 31, 2012	40,833,000
Dec 31, 2011	56,873,000
Dec 31, 2010	56,454,611
Dec 31, 2009	42,437,498
Dec 31, 2008	137,066,027
Dec 31, 2007	51,217,617
Dec 31, 2006	31,916,000
Dec 31, 2005	18,729,368
Dec 31, 2004	16,398,629
Dec 31, 2003	20,121,000
Dec 31, 2002	19,822,089
Dec 31, 2001	49,485,497
Dec 31, 2000	15,096,509
Dec 31, 1999	13,300,000
Dec 31, 1998	19,800,000
Dec 31, 1997	23,500,000
Dec 31, 1996	10,100,000
Dec 31, 1995	14,300,000
Dec 31, 1994	5,200,000